Abstract
Infection remains a major cause of death and morbidity in patients undergoing cardiac transplantation, especially in the first few months when immunosuppression is at its highest1–9. Study of these infections provides an alarming, though fascinating, insight into the delicate relationship between the transplant recipient and the wide variety of organisms, both pathogens and opportunists, in our environment. Although bacteria are the most common causative organisms (30–60%), other etiological agents such as viruses (20–50%), fungi (14–25%), and protozoa (up to 5%), account for a proportion of infectious episodes3, 4. In our own and other centers, these complications have prompted a critical assessment of conditions favoring infection, of means for preventing them, and of diagnostic approaches to identification of causative organisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baumgartner, W.A., Reitz, B.A., Oyer, P.E., Stinson, E.B. and Shumway, N.E. (1979). Cardiac homotransplantation. Curr. Probl. Surg., 16, 1
Barnard, C.N., Barnard, M.S., Cooper, D.K.C., Curchio, C.A., Hassoulas, J., Novitzky, D. and Wolpowitz, A. (1981). The present status of heterotopic cardiac transplantation. J. Thorac. Cardiovasc. Surg., 81, 433
Cooper, D.K.C., Lanza, R.P., Oliver, S.P., Forder, A.A., Rose, A.G., Uys, C.J., Novitzky, D. and Barnard, C.N. (1983). Infectious complications following heterotopic heart transplantation. Thorax, 38, 822
Hofflin, J.M., Potasman, I, Baldwin, J.C., Oyer, P.E, Stinson, E.B. and Remington, J.S. (1987). Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann. Intern. Med., 106, 209
Renlund, D.G., Gilbert, E.M., O’Connell, J.B., Gay, W.A., Jones, K.W., Burton, N.A., Doty, D.B., Karawnde, S.V., DeWitt, C.W., Menlove, R.L., Herrick, C.M. and Bristow, M.R. (1987). Age-associated decline in cardiac allograft rejection. Am. J. Med., 83, 391
Baumgartner, W.A., Augustine, S., Borkon, M., Gardner, T.J. and Reitz, B.A. (1987). Present expectations in cardiac transplantation. Ann. Thorac. Surg., 43. 585
Gentry, L.O. and Zeluif, B.J. (1986). Diagnosis and treatment of infection in cardiac transplant patients. Surg. Clin. North Am., 66, 459
Emery, R.W., Cork, R., Christensen, R., Levinson, M.M., Icenogle, T.B., Riley, J., Ott, R.A. and Copeland, J.G. (1986). Cardiac transplantpatients at one year. Cyclosporine vs. conventional immunosuppression. Chest, 90, 29
Schulman, L., Smith, C., Drusin, R., Rose, E., Enson, Y. and Reemtsma, K. (1986). Respiratory complications of heart transplantation. J. Heart Transplant., 5, 387
Rubin, R.H., Wolfson, J.S. and Cosimi, A.G. (1981). Infection in the renal transplant recipient. In Dixon, R.E. (ed.) Nosocomial Infections. p. 121. (New York: Yorke Medical Books)
Jamieson, S.W., Stinson, E.B. and Shumway, N.E. (1982). Cardiac transplantation. In Morris, P.J. (ed.) Tissue Transplantation. p. 147. (Edinburgh: Churchill Livingstone)
Baumgartner, W.A. (1983). Infection in cardiac transplantation. Heart Transplant., 3, 75
Fabre, J.W. (1982). Specific immunosuppression. In Morris, PJ. (ed.) Tissue Transplantation. p. 80. (Edinburgh: Churchill Livingstone)
Cooper, D.K.C., Lanza, R.P. and Barnard, C.N. (1984). Non-compliance in heart transplant recipients: the Cape Town experience. Heart Transplant. 3, 248
Parker, M.T. (1978). Microbiological facilities for the surveillance and control of the spread of infection in hospitals. In Daschner, F. (ed.) Proven and Unproven Methods in Hospital Infection Control. p. 35. (Stuttgart: Fischer)
Snydman, D.R., Werner, B.G., Heinze-Lacey, B., Berardi, V.P., Tilney, N.L., Kirkman, R.L., Milford, E.L., Cho, S.I., Bush, H.L., Levey, A.S., Strom, T.B., Carpenter, C.B., Levey, R.H., Harmon, W.E., Zimmerman, C.E., Shapiro, M.E., Steinman, T., Logerfo, F., Idelson, B., Shroter, P.J., Levin, M.J., Mclver, J., Leszczynski, J. and Grady, G.F. (1987). Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N. Engl. J. Med., 317, 1049
Wreghitt, T.G., Gray, JJ. and Balfour, A.H. (1986). Problems with serological diagnosis of Toxoplasma gondii infections in heart transplant recipients. J. Clin. Pathol., 39, 1135
Hakim, M., Esmore, D., Wallwork, J., English, T.A.H. and Wreghitt, T. (1986). Toxoplasmosis in cardiac transplantation. Br. Med. J., 202, 1108
Minoli, L., Grossi, P., Marone, P., Maserati, R., Malfitano, A., Martinelli, L. and Sessa, F. (1986). Are HBsAg carriers suitable for heart transplantation? J. Heart Transplant., 5, 364
Applefeld, M.M., Newman, K.A., Sutton, F.J., Reed, W.P., Roffman, D.S., Talesnick, B.S. and Grove, W.R. (1987). Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients. Am. Heart J., 114, 589
Frist, W.H., Oyer, P.E., Baldwin, J.C, Stinson, E.B. and Shumway, N.E. (1987). HLA compatibility and cardiac transplant recipient survival. Ann. Thorac. Surg., 44, 242
Hess, N. (1986). Update on infection rates with only protective isolation. J. Heart Transplant., 5, 393
McKenzie, F.N., Menkis, A.H., Tadros, N, Stiller, C.R., Keown, P.A. and Kostuk, W.F. (1986). The limited role of protective isolation after heart transplantation. J. Heart Transplant., 5, 381
Gamberg, P., Miller, J. and Lough, M.E. (1986). Impact of protective isolation on the incidence of infection after heart transplantation. J. Heart Transplant., 5, 378
Preston, G.A., Larson, E.L. and Stamm, W.E. (1981). The effect of private isolation rooms on patient care practices, colonization and infection in an intensive care unit. In Dixon, R.E. (ed.) Nosocomial Infections. p. 285. (Atlanta: Yorke Medical Books)
Armstrong, D. (1981). The diagnostic microbiology laboratory in the care of the immunosuppressed patient. In Lorian, V. (ed.) Significance of Medical Microbiology in Care of Patients. p. 73. (Baltimore: Williams & Wilkins)
Bartlett, J.G. (1982). Making optimum use of the microbiology laboratory. J. Am. Med. Assoc., 247, 857 (Part 1), 1336 (Part 2), 1868 (Part 3)
Matthay, R.A. and Moritz, E.D. (1981). Invasive procedures for diagnosing pulmonary infection. A critical review. Clin. Chest Med., 2, 3
Bartlett, J.G. (1977). Diagnostic accuracy of transtracheal aspiration: bacteriologic studies. Am. Rev. Respir. Dis., 115, 777
Zavala, D.C. and Schoell, J.E. (1981). Ultra-thin needle aspiration of the lung in infectious and malignant disease. Am. Rev. Respir. Dis., 123, 125
Wimberley, N., Faling, L.J. and Bartlett, J.G. (1979). A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am. Rev. Respir. Dis., 119, 337
Willcox, P.A., Benatar, S.R., Potgieter, P.D., Ferguson, A.D. and Bateman, E.D. (1981). Fiberoptic bronchoscopy: experience at Groote Schuur Hospital. S. Afr. Med. J., 60, 651
Beyt, B.E., King, D.K. and Glew, R.H. (1977). Fatal pneumonitis and septicaemia after fiberoptic bronchoscopy. Chest, 72, 105
Robbins, H. and Goldman, A.L. (1977). Failure of a ’prophylactic’ antimicrobial drug to prevent sepsis after fiberoptic bronchoscopy. Am. Rev. Respir. Dis., 116, 325
Willcox, P.A., Bateman, E.D., Potgieter, P.D. and Benatar, S.R. (1987). Is fiberoptic bronchoscopy of value in the diagnosis of pulmonary shadows in renal transplant recipients? Am. Rev. Respir. Dis., 135A, 411
Meyers, J.D. and Thomas, E.D. (1981). Infection complicating bone marrow transplantation. In Rubin, R.H. and Young, L.S. (eds.) Clinical Approach to Infection in the Compromised Host. p. 507. (New York: Plenum)
Britt, R.H., Enzmann, D.R. and Remington, J.S. (1981). Intracranial infection in cardiac transplant recipients. Ann. Neurol., 9, 107
Young, L.S. (1981). Fever and septicaemia. In Rubin, R.H. and Young, L.S. (eds.) Clinical Approach to Infection in the Compromised Host. p. 75. (New York: Plenum)
Penn, R.L., Lambert, R.S. and George, R.B. (1983). Invasive fungal infections. The use of serologic tests in diagnosis and management. Arch. Intern. Med., 143, 1215
Rubin, R.H. and Greene, R. (1981). Etiology and management of the compromised patient with fever and pulmonary infiltrates. In Rubin, R.H. and Young, L.S. (eds.) Clinical Approach to Infection in the Compromised Host. p. 123. (New York: Plenum)
Fisher, B.D. and Armstrong, D. (1977). Cryptococcal interstitial pneumonia: value of antigen determination. N. Engl. J. Med., 297, 1440
Van der Bij, W., Van Dijk, R.B., Prenger, K.B., Prop, J., Torensma, R. and The, T.H. (1986). Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients. J. Heart Transplant., 5, 364
Rubin, R.H. (1981). Infection in the renal transplant patient. In Rubin, R.H. and Young, L.S. (eds.) Clinical Approach to Infection in the Compromised Host. p. 553. (New York: Plenum)
Smith, C.R., Lipsky, J.J., Laskin, O.L., Hellman, D.B., Mellits, E.D., Longstreth, S. and Lietman, P.S. (1980). Double-blind comparison of the nephrotoxicity of gentamicin and tobramycin. N. Engl. J. Med., 302, 1106
Tuder, R.M., Renya, G.S. and Bensch, K. (1986). Mycobacterial coronary arteritis in a heart transplant recipient. Hum. Pathol., 17, 1072
Simon, H.B. (1981). Mycobacterial and nocardial infections in the compromised host. In Rubin, R.H. and Young, L.S. (eds.) Clinical Approach to Infection in the Compromised Host. p. 229. (New York: Plenum)
Rand, K.H., Pollard, R.B. and Merigan, T.C. (1978). Increased pulmonary superinfections in cardiac transplant patients undergoing primary cytomegalovirus infection. N. Engl. J. Med., 298, 951
Chou, S. (1987). Cytomegalovirus infection and reinfection transmitted by heart transplantation. J. Infect. Dis., 155, 1054
Icenogle, T.B., Peterson, E., Ray, G., Minnich, L. and Copeland, J.G. (1987). DHPG effectively treats CMV infection in heart and heart—lung transplant patients: a preliminary report. J. Heart Transplant., 6, 199
Min, K.W., Wickemeyer, WJ., Chandran, P, Shadur, C, Gervich, D, Phillips, S.J., Zeff, R.H. and Song, J. (1986). Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: a case report. J. Heart Transplant., 5, 375
Havel, M., Laczkovics, A., Laufer, G., Spiss, C., Muller, M.M. and Wolner, E. (1986). Cytomegalovirus hyperimmunoglobulin prophylaxis after heart transplantation. J. Heart Transplant., 5, 398
Schulman, L.L. (1987). Cytomegalovirus pneumonitis and lobar consolidation. Chest, 91, 558
Tobin, J.O.H. (1983). Virus infections in the immunocompromised. In Waterson, A.P. (ed.) Recent Advance in Clinical Virology. No. 3. p. 1. (Edinburgh: Churchill Livingstone)
Watson, F.S., O’Connell, J.B., Amber, I.J., Renlund, D.G. and Bristow, M.R. (1986). Treatment of cytomegalovirus pneumonia in heart transplant recipients with DHPG. J. Heart Transplant., 5, 390
Locke, T.J., Odom, N.J., Tapson, J.S., Freeman, R. and McGregor, C.G.A. (1987). Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation. J. Heart Transplant., 6, 120
Uys, C.J., Rose, A.G. and Barnard, C.N. (1979). The pathology of human cardiac transplantation. S. Afr. Med. J., 56, 887
Alford, C.A. (1982). Acyclovir treatment of herpes virus infections in immunocompromised humans. Am. J. Med., 73 (Suppl.), 225
Armstrong, D. (1981). Fungal infections in the compromised host. In Rubin, R.H. and Young, L.S. (eds.) Clinical Approach to Infection in the Compromised Host. p. 195. (New York: Plenum)
Kerkering, T.M., Duma, RJ. and Shadomy, S. (1981). The evolution of pulmonary cryptococcosis. Clinical implications from a study of 41 patients with and without compromising host factors. Ann. Intern. Med., 94, 611
Butler, W.T., Ailing, D.W., Spickard, A., and Utz, J.P. (1964). Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis. A follow-up study of 40 patients. N. Engl. J. Med., 59, 270
Hammerman, K.J., Powell, K.E., Christianson, C.S., Huggin, P.M., Larsh, H.W., Vivas, J.R. and Tosh, F.E. (1973). Pulmonary cryptococcosis: clinical forms and treatment. A center for disease control cooperative mycoses study. Am. Rev. Respir. Dis., 108, 1116
Medoff, G. and Kobayashi, G.S. (1980). Strategies in the treatment of systemic fungal infections. N. Engl. J. Med., 302, 45
Edwards, J.E., Lehrer, R.I., Stiehm, E.R., Fischer, T.J. and Young, L.S. (1978). Severe candidal infections. Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann. Intern. Med., 89, 91
Walker, D.H., Adamec, T. and Krigman, M. (1978). Disseminated petriellidosis (Allescheriosis). Arch. Pathol. Lab. Med., 102, 158
Murray-Leisure, K.A., Aber, R.C., Rowley, L.J., Applebaum, P.C., Wisman, C.B., Pennock, J.L. and Pierce, W.S. (1986). Disseminated Trichosporon beigelii (cutaneum) infection in an artificial heart recipient. J. Am. Med. Assoc., 256, 2995
Walzer, P.D., Perl, D.P., Krogstad, D.J., Rawson, P.G. and Schultz, M.G. (1974). Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic and clinical features. Ann. Intern. Med., 80, 83
Winston, D.J, Lau, W.K., Gale, R.P. and Young, L.S. (1980). Trimetho-primsulphamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann. Intern. Med., 92, 762
Luce, J.M. (1986). Sputum induction in the acquired immunodeficiency syndrome. Am. Rev. Respir. Dis., 133, 513
Debs, R.J, Straubinger, R.M, Brunette, E.N, Lin, J.M, Lin, E.J, Montgomery, A.B., Friend, D.S. and Papahadjopoulos, D.P. (1987). Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes. Am. Rev. Respir. Dis., 135, 731
Hughes, W.T, Kuhn, S, Chaudhary, S, Feldman, S, Verzosa, M, Aur, R.J.A, Pratt, C. and George, S.L. (1977). Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N. Engl. J. Med., 297, 1419
Rose, A.G, Uys, C.J, Novitzky, D, Cooper, D.K.C. and Barnard, C.N. (1983). Toxoplasmosis of donor and recipient heart after heterotopic cardiac transplantation. Arch. Pathol. Lab. Med., 197, 368
Potasman, I, Araujo, F.G, Desmonts, G. and Remington, J.S. (1986). Analysis of Toxoplasma gondii antigens recognized by human sera obtained before and after acute infection. J. Infect. Dis., 154, 650
Jones, R.J. (1981). Vaccines and antisera against Gram-negative bacilli. J. Hosp. Infect., 2, 105
Gaffin, S.L. (1982). Control of septic shock — present day concept. S. Afr. J. Hosp. Med., 8, 4
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bateman, E.D., Forder, A.A. (1990). Infectious Complications. In: Cooper, D.K.C., Novitzky, D. (eds) The Transplantation and Replacement of Thoracic Organs. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0711-9_17
Download citation
DOI: https://doi.org/10.1007/978-94-009-0711-9_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6805-5
Online ISBN: 978-94-009-0711-9
eBook Packages: Springer Book Archive